HSC70 is a novel binding partner involved in the capture of immunoglobulins on B cells in the NOD mouse

References

• Ferguson AR, Youd ME, Corley RB. Marginal zone B cells transport and deposit IgM-containing immune complexes onto follicular dendritic cells. Int Immunol. 2004;16(10):1411–1422.
   PubMed Web of Science ®Google Scholar
• Phan TG, Grigorova I, Okada T, et al. Subcapsular encounter and complement-dependent transport of immune complexes by lymph node B cells. Nat Immunol. 2007;8(9):992–1000.
   PubMed Web of Science ®Google Scholar
• Cinamon G, Zachariah MA, Lam OM, et al. Follicular shuttling of marginal zone B cells facilitates antigen transport. Nat Immunol. 2008;9(1):54–62.
   PubMed Web of Science ®Google Scholar
• Shibuya A, Sakamoto N, Shimizu Y, et al. Fcα/μ receptor mediates endocytosis of IgM-coated microbes. Nat Immunol. 2000;1(5):441–446.
   PubMed Web of Science ®Google Scholar
• Quah BJ, Barlow VP, McPhun V, et al. Bystander B cells rapidly acquire antigen receptors from activated B cells by membrane transfer. Proc Natl Acad Sci U S A. 2008;105(11):4259–4264.
   PubMed Web of Science ®Google Scholar
• Silveira PA, Grey ST. B cells in the spotlight: innocent bystanders or major players in the pathogenesis of type 1 diabetes. Trends Endocrinol Metab. 2006;17(4):128–135.
   PubMed Web of Science ®Google Scholar
• Makino S, Kunimoto K, Muraoka Y, et al. Breeding of a non-obese, diabetic strain of mice. Jikken Dobutsu. 1980;29(1):1–13.
   PubMedGoogle Scholar
• Magnuson AM, Thurber GM, Kohler RH, et al. Population dynamics of islet-infiltrating cells in autoimmune diabetes. Proc Natl Acad Sci U S A. 2015;112(5):1511–1516.
   PubMed Web of Science ®Google Scholar
• Ziegler AG, Nepom GT. Prediction and pathogenesis in type 1 diabetes. Immunity. 2010;32(4):468–478.
   PubMed Web of Science ®Google Scholar
• Akashi T, Nagafuchi S, Anzai K, et al. Direct evidence for the contribution of B cells to the progression of insulitis and the development of diabetes in non-obese diabetic mice. Int Immunol. 1997;9(8):1159–1164.
   PubMed Web of Science ®Google Scholar
• Forsgren S, Andersson A, Hillorn V, et al. Immunoglobulin-mediated prevention of autoimmune diabetes in the non-obese diabetic (NOD) mouse. Scand J Immunol. 1991;34(4):445–451.
   PubMed Web of Science ®Google Scholar
• Xiu Y, Wong CP, Bouaziz JD, et al. B lymphocyte depletion by CD20 monoclonal antibody prevents diabetes in nonobese diabetic mice despite isotype-specific differences in Fc gamma R effector functions. J Immunol. 2008;180(5):2863–2875.
   PubMed Web of Science ®Google Scholar
• Falcone M, Lee J, Patstone G, et al. B lymphocytes are crucial antigen-presenting cells in the pathogenic autoimmune response to GAD65 antigen in nonobese diabetic mice. J Immunol. 1998;161(3):1163–1168.
   PubMed Web of Science ®Google Scholar
• Noorchashm H, Lieu YK, Noorchashm N, et al. I-Ag7-mediated antigen presentation by B lymphocytes is critical in overcoming a checkpoint in T cell tolerance to islet beta cells of nonobese diabetic mice. J Immunol. 1999;163(2):743–750.
   PubMed Web of Science ®Google Scholar
• Serreze DV, Silveira PA. The role of B lymphocytes as key antigen-presenting cells in the development of T cell-mediated autoimmune type 1 diabetes. Curr Dir Autoimmun. 2003;6:212–227.
   PubMedGoogle Scholar
• Leijon K, Hammarstrom B, Holmberg D. Non-obese diabetic (NOD) mice display enhanced immune responses and prolonged survival of lymphoid cells. Int Immunol. 1994;6(2):339–345.
   PubMed Web of Science ®Google Scholar
• Pedotti R, Sanna M, Tsai M, et al. Severe anaphylactic reactions to glutamic acid decarboxylase (GAD) self peptides in NOD mice that spontaneously develop autoimmune type 1 diabetes mellitus. BMC Immunol. 2003;4:2.
   PubMedGoogle Scholar
• Leijon K, Freitas A, Holmberg D. Analysis of VH gene utilisation in the non-obese diabetic mouse. Autoimmunity. 1993;15(1):11–18.
   PubMed Web of Science ®Google Scholar
• Ekici R, Sundstrom M, Thay B, et al. Enhanced capture of extramembranous IgM and IgG on B cells in the NOD mouse–implications for immune complex trapping. Int Immunol. 2009 May;21(5):533–541.
   PubMed Web of Science ®Google Scholar
• Stolp J, Marino E, Batten M, et al. Intrinsic molecular factors cause aberrant expansion of the splenic marginal zone B cell population in nonobese diabetic mice. J Immunol. 2013;191(1):97–109.
   PubMed Web of Science ®Google Scholar
• Stricher F, Macri C, Ruff M, et al. HSPA8/HSC70 chaperone protein: structure, function, and chemical targeting. Autophagy. 2013;9(12):1937–1954.
   PubMed Web of Science ®Google Scholar
• Bonam SR, Ruff M, Muller S. HSPA8/HSC70 in immune disorders: a molecular rheostat that adjusts chaperone-mediated autophagy substrates. Cells. 2019;8(8):849.
   Web of Science ®Google Scholar
• Eisenberg E, Greene LE. Multiple roles of auxilin and hsc70 in clathrin-mediated endocytosis. Traffic. 2007;8(6):640–646.
   PubMed Web of Science ®Google Scholar
• Auger I, Escola JM, Gorvel JP, et al. HLA-DR4 and HLA-DR10 motifs that carry susceptibility to rheumatoid arthritis bind 70-kD heat shock proteins. Nat Med. 1996;2(3):306–310.
   PubMed Web of Science ®Google Scholar
• Panjwani N, Akbari O, Garcia S, et al. The HSC73 molecular chaperone: involvement in MHC class II antigen presentation. J Immunol. 1999;163(4):1936–1942.
   PubMed Web of Science ®Google Scholar
• Guerrero CA, Bouyssounade D, Zarate S, et al. Heat shock cognate protein 70 is involved in rotavirus cell entry. J Virol. 2002;76(8):4096–4102.
   PubMed Web of Science ®Google Scholar
• Mills DR, Haskell MD, Callanan HM, et al. Monoclonal antibody to novel cell surface epitope on Hsc70 promotes morphogenesis of bile ducts in newborn rat liver. Cell Stress Chaperones. 2010;15(1):39–53.
   PubMed Web of Science ®Google Scholar
• Page N, Gros F, Schall N, et al. HSC70 blockade by the therapeutic peptide P140 affects autophagic processes and endogenous MHCII presentation in murine lupus. Ann Rheum Dis. 2011 May;70(5):837–843.
   PubMed Web of Science ®Google Scholar
• Perez-Vargas J, Romero P, Lopez S, et al. The peptide-binding and ATPase domains of recombinant hsc70 are required to interact with rotavirus and reduce its infectivity. J Virol. 2006;80(7):3322–3331.
   PubMed Web of Science ®Google Scholar
• Vega-Almeida TO, Salas-Benito M, De Nova-Ocampo MA, et al. Surface proteins of C6/36 cells involved in dengue virus 4 binding and entry. Arch Virol. 2013;158(6):1189–1207.
   PubMed Web of Science ®Google Scholar
• Gutierrez M, Isa P, Sanchez-San Martin C, et al. Different rotavirus strains enter MA104 cells through different endocytic pathways: the role of clathrin-mediated endocytosis. J Virol. 2010;84(18):9161–9169.
   PubMed Web of Science ®Google Scholar
• Rodriguez LS, Barreto A, Franco MA, et al. Immunomodulators released during rotavirus infection of polarized caco-2 cells. Viral Immunol. 2009;22(3):163–172.
   PubMed Web of Science ®Google Scholar
• Zou N, Ao L, Cleveland JC, Jr., et al. Critical role of extracellular heat shock cognate protein 70 in the myocardial inflammatory response and cardiac dysfunction after global ischemia-reperfusion. Am J Physiol Heart Circ Physiol. 2008;294(6):H2805–H2813.
   PubMed Web of Science ®Google Scholar
• Niu L, Lou F, Sun Y, et al. A micropeptide encoded by lncRNA MIR155HG suppresses autoimmune inflammation via modulating antigen presentation. Sci Adv. 2020 May;6(21):eaaz2059.
   PubMed Web of Science ®Google Scholar
• Fishelson Z, Hochman I, Greene LE, et al. Contribution of heat shock proteins to cell protection from complement-mediated lysis. Int Immunol. 2001;13(8):983–991.
   PubMed Web of Science ®Google Scholar
• Hirai I, Sato N, Qi W, et al. Localization of pNT22 70 kDa heat shock cognate-like protein in the plasma membrane. Cell Struct Funct. 1998;23(3):153–158.
   PubMed Web of Science ®Google Scholar
• Aquino DA, Capello E, Weisstein J, et al. Multiple sclerosis: altered expression of 70- and 27-kDa heat shock proteins in lesions and myelin. J Neuropathol Exp Neurol. 1997;56(6):664–672.
   PubMed Web of Science ®Google Scholar
• Schick C, Arbogast M, Lowka K, et al. Continuous enhanced expression of Hsc70 but not Hsp70 in rheumatoid arthritis synovial tissue. Arthritis Rheum. 2004;50(1):88–93.
   PubMedGoogle Scholar
• Kubota H, Yamamoto S, Itoh E, et al. Increased expression of co-chaperone HOP with HSP90 and HSC70 and complex formation in human colonic carcinoma. Cell Stress Chaperones. 2010;15(6):1003–1011.
   PubMed Web of Science ®Google Scholar
• Sun G, Cao Y, Xu Y, et al. Overexpression of Hsc70 promotes proliferation, migration, and invasion of human glioma cells. J Cell Biochem. 2019;120(6):10707–10714.
   PubMed Web of Science ®Google Scholar
• Arosio A, Cristofani R, Pansarasa O, et al. HSC70 expression is reduced in lymphomonocytes of sporadic ALS patients and contributes to TDP-43 accumulation. Amyotroph Lateral Scler Frontotemporal Degener. 2020;21(1–2):51–62.
   PubMed Web of Science ®Google Scholar
• Piedrahita D, Castro-Alvarez JF, Boudreau RL, et al. β-secretase 1’s targeting reduces hyperphosphorilated tau, implying autophagy actors in 3xTg-AD mice. Front Cell Neurosci. 2015;9:498.
   PubMed Web of Science ®Google Scholar
• Lagaudriere-Gesbert C, Newmyer SL, Gregers TF, et al. Uncoating ATPase Hsc70 is recruited by invariant chain and controls the size of endocytic compartments. Proc Natl Acad Sci U S A. 2002;99(3):1515–1520.
   PubMed Web of Science ®Google Scholar
• Eckenrode SE, Ruan Q, Yang P, et al. Gene expression profiles define a key checkpoint for type 1 diabetes in NOD mice. Diabetes. 2004;53(2):366–375.
   PubMed Web of Science ®Google Scholar
• Nadeau K, Nadler SG, Saulnier M, et al. Quantitation of the interaction of the immunosuppressant deoxyspergualin and analogs with Hsc70 and Hsp90. Biochemistry. 1994;33(9):2561–2567.
   PubMed Web of Science ®Google Scholar
• Nadler SG, Dischino DD, Malacko AR, et al. Identification of a binding site on Hsc70 for the immunosuppressant 15-deoxyspergualin. Biochem Biophys Res Commun. 1998;253(1):176–180.
   PubMed Web of Science ®Google Scholar
• Haberstroh J, Wilhelm T, Schulte-Monting J, et al. Prevention of type I diabetes in the non-obese diabetic (NOD) mouse with 15-deoxyspergualin (15-DS) or 15-DS + cyclosporin A (CyA). Immunol Lett. 1995;48(2):117–121.
   PubMed Web of Science ®Google Scholar